Disclosures: Standards of Medical Care in Diabetes —2022

Committee members disclosed the following financial or other conflicts of interest (COI) covering the period 12 months before December 2021MemberEmploymentResearch grantOther research supportSpeakers ’ bureau/honorariaOwnership interestConsultant/advisory boardOtherProfessional Practice CommitteeBoris Draznin, MD, PhD (Chair)University of Colorado Denver, School of MedicineNoneNoneNoneNoneNoneeDoctate (unpaid professional education)Vanita R. Aroda, MDBrigham and Women ’s Hospital Faculty, Harvard Medical SchoolApplied Therapeutics##, Eli Lilly##, Fractyl##, Novo Nordisk##NoneNoneJanssen (spouse employee benefits)Applied Therapeutics##, Novo Nordisk**##, Pfizer, SanofiJanssen Pharmaceutical Companies of Johnson& Johnson (spouse Sandip Datta, MD, Senior Director, Translational Sciences, Immunology, May 2020 to present) Consultant/Educational Activities: American College of Cardiology, American Diabetes Association, Cardiometabolic Health Congress, Endocrine Society, Hello Diabetes Academia, PeerView, PeerVoiceGeorge Bakris, MDUniversity of Chicago MedicineNoneNoneNoneNoneMerck, Novo Nordisk, Bayer, KBP Biosciences, Ionis, Alnylam, AstraZeneca, Quantum Genomics, Horizon, DiaMedica TherapeuticsEditor ofAmerican Journal of NephrologyGretchen Benson, RDN, LD, CDCESMinneapolis Heart Institute FoundationNoneNoneNoneNoneNoneNoneFlorence M. Brown, MDJoslin Diabetes Center, Inc.Dexcom## ††NoneNoneNoneNoneNoneRaShaye Freeman, DNP, FNP-BC, CDCES, ADM-BCHCA HealthcareNoneNoneNo...
Source: Diabetes Care - Category: Endocrinology Source Type: research